Federal Register of Legislation - Australian Government

Primary content

PB 92 of 2020 Determinations/Health as made
This instrument amends the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012) to make changes to the list of pharmaceutical benefits that may be supplied by medical practitioners and authorised nurse practitioners, respectively, directly to patients (prescriber bag supplies) and to the maximum quantity or number of units of these pharmaceutical benefits which may be obtained during a specified period by a medical practitioner and an authorised nurse practitioner.
Administered by: Health
Registered 30 Sep 2020
Tabling HistoryDate
Tabled HR06-Oct-2020
Tabled Senate06-Oct-2020

PB 92 of 2020

 

National Health (Prescriber bag supplies) Amendment Determination 2020 (No. 4)

 

National Health Act 1953

___________________________________________________________________________

 

I, THEA CONNOLLY, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under sections 93 and 93AB of the National Health Act 1953.

 

Dated                  28 September 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THEA CONNOLLY

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 


 

___________________________________________________________________________

1          Name of Determination

(1)          This Determination is the National Health (Prescriber bag supplies) Amendment Determination 2020 (No. 4).

(2)          This Determination may also be cited as PB 92 of 2020.

2          Commencement

This Determination commences on 1 October 2020.

3          Amendment of National Health (Prescriber bag supplies) Determination 2012

Schedule 1 amends the National Health (Prescriber bag supplies) Determination 2012 (PB 73 of 2012).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                             

                             


Schedule 1  Amendments

[1]        Schedule,

omit table and substitute:

Group Number

Listed Drug

Form

Prescriber Bag Supplier

Maximum Quantity

1

Adrenaline (epinephrine)

Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000)

MP, NP

5

3

Atropine

Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL

MP, NP

10

58

Benzathine benzylpenicillin

Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe

MP, NP

10

31

Benzatropine

Injection containing benzatropine mesilate 2 mg in 2 mL

MP, NP

5

17

Benzylpenicillin

Powder for injection 600 mg (as sodium)

MP, NP

5

32

Benzylpenicillin

Powder for injection 3 g (as sodium)

MP, NP

1

4

Chlorpromazine

Injection containing chlorpromazine hydrochloride 50 mg in 2 mL

MP, NP

10

34

Clonazepam

Oral liquid 2.5 mg per mL, 10 mL

MP, NP

1

25

Diphtheria and tetanus vaccine, adsorbed, diluted for adult use

Injection 0.5 mL in pre‑filled syringe

MP, NP

10

10

Furosemide

Injection 20 mg in 2 mL

MP, NP

5

26

Glucagon

Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe

MP, NP

1

30

Glyceryl Trinitrate

Sublingual spray (pump pack) 400 micrograms per dose, 200 doses

MP, NP

1

4

Haloperidol

Injection 5 mg in 1 mL

MP, NP

10

12

Hydrocortisone

Injection 100 mg (as sodium succinate) with 2 mL solvent

MP, NP

2

12

Hydrocortisone

Injection 250 mg (as sodium succinate) with 2 mL solvent

MP, NP

1

33

Hyoscine

Injection containing hyoscine butylbromide 20 mg in 1 mL

MP, NP

5

54

Lidocaine

Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL

MP, NP

5

35

Methoxyflurane

Liquid for inhalation 999 mg per g, 3 mL (with inhaler)

MP

1

18

Metoclopramide

Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL

MP, NP

10

53

Midazolam

Injection 5 mg (as hydrochloride) in 1 mL

MP, NP

10

14

Morphine

Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL

MP, NP

5

14

Morphine

Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL

MP, NP

5

14

Morphine

Injection containing morphine sulfate pentahydrate 15 mg in 1 mL

MP, NP

5

14

Morphine

Injection containing morphine sulfate pentahydrate 30 mg in 1 mL

MP, NP

5

57

Naloxone

Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule

MP, NP

10

55

Phytomenadione

Injection 10 mg in 1 mL

MP

5

17

Procaine benzylpenicillin

Injection 1.5 g in disposable syringe

MP, NP

5

18

Prochlorperazine

Injection containing prochlorperazine mesilate 12.5 mg in 1 mL

MP, NP

10

19

Promethazine

Injection containing promethazine hydrochloride 50 mg in 2 mL

MP, NP

10

59

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

MP, NP

1

59

Salbutamol

Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30

MP, NP

1

28

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

MP, NP

1

28

Salbutamol

Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

MP, NP

1

59

Salbutamol

 

Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation)

MP, NP

1

59

Salbutamol

Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation)

MP, NP

1

16

Tramadol

Injection containing tramadol hydrochloride 100 mg in 2 mL

MP, NP

5